◀ Back to IRF6

CCL18 — IRF6

Text-mined interactions from Literome

Sironi et al., J Leukoc Biol 2006 (Arthritis, Rheumatoid) : In contrast, FcgammaR stimulation inhibited the IL-10- and LPS mediated induction of CCL18
Ferrara et al., Scand J Immunol 2008 (Tuberculosis, Pulmonary) : Stimulation of MDM with LPS or MTB led to a significant increase in CCL18 protein ( control 2.67 +/- 0.46 ng/ml, LPS 4.05 +/- 0.56 ng/ml, with MTB 6.70 +/- 1.59 ng/ml, n = 5, P < 0.05 ) and specific mRNA levels ( control 0.09 +/- 0.01, LPS 0.24 +/- 0.11, with MTB 0.34 +/- 0.08 CCL18/Glyceraldehyde 3-phosphate dehydrogenase ( GAPDH ), n = 3, P < 0.05 )
Cai et al., Immunobiology 2013 (Cryptogenic Organizing Pneumonia) : CAM and AZM significantly and dose-dependently attenuated the LPS stimulated production of sTNFR1, sTNFR2, IL-8 and CCL18 ( p < 0.05 )